Keyphrases
Antiviral Activity
100%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
100%
HIV Drugs
100%
Drug Target
75%
Dose-response Curve
75%
Cooperativity
50%
Nucleoside Reverse Transcriptase Inhibitors
50%
Drug Concentration
50%
Virus
25%
HIV-1 Replication
25%
Ligand Binding
25%
Inhibition Rate
25%
Drug Class
25%
Protease Inhibitors
25%
Model Fitting
25%
Infectivity
25%
Good Target
25%
Pharmacodynamics
25%
Hill Coefficient
25%
Antiviral Drugs
25%
Model Prediction
25%
Target Molecule
25%
Multi-copy
25%
IC50
25%
Life Cycle Stages
25%
Multivalent
25%
Virus Response
25%
Integrase Strand Transfer Inhibitor (INSTI)
25%
HIV-1 Treatment
25%
Virus Population
25%
Individual Life
25%
Inhibitory Potential
25%
Univalent
25%
Unbound States
25%
Biochemistry, Genetics and Molecular Biology
Dose Response
100%
Antiviral Activity
100%
Human Immunodeficiency Virus
100%
Reverse Transcriptase
100%
Nucleoside
66%
Cooperation
66%
Human Immunodeficiency Virus 1
66%
Drug Concentration
66%
Life Cycle
33%
Ligand Binding
33%
Integrase
33%
Pharmacodynamics
33%
Hill Coefficient
33%
IC50
33%
Protease Inhibitor
33%
Life Cycle Stage
33%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiviral Activity
100%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Dose Response
75%
Virus
75%
Cooperation
50%
Life Cycle
50%
Reverse-Transcriptase Inhibitor
50%
Infection
25%
Receptor
25%
Proteinase Inhibitor
25%
Pharmacodynamics
25%
IC50
25%
Integrase
25%
Antiviral Drug
25%
Ligand Binding
25%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Antiviral Activity
100%
RNA Directed DNA Polymerase Inhibitor
50%
Drug Concentration
50%
Infection
25%
Receptor
25%
Pharmacodynamics
25%
Proteinase Inhibitor
25%
IC50
25%
Integrase
25%
Life Cycle Stage
25%
Antiviral Drug
25%